News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Alzheon Appoints Renowned Industry Leader, Jean-Pierre Sommadossi, PhD, To Board Of Directors



8/5/2014 10:01:58 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Alzheon, Inc., a clinical-stage biopharmaceutical company focused on brain health, memory and aging, announced today that it has appointed Jean-Pierre Sommadossi, PhD, to the company’s Board of Directors. With more than 20 years of scientific, operational, strategic and management experience in the biotechnology industry, Dr. Sommadossi brings a seasoned and unique perspective to support Alzheon’s continued growth and advancement as a leading clinical-stage Alzheimer’s company.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
Alzheon
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES